Lebanon’s National Social Security Fund (NSSF) has expanded its drug coverage in a major healthcare move, adding 1,067 previously excluded medications back to its reimbursement list. The update, announced Thursday by NSSF Director General Mohammad Karake, restores up to 80% reimbursement for these drugs—returning to pre-crisis coverage levels.
The revision follows a re-pricing process based on the official medication price index released by the Ministry of Public Health on March 4, 2025. The NSSF’s medical control department, alongside verifying pharmacists, reviewed and adjusted the rates accordingly.
The changes apply to nearly 4,200 pharmaceutical products registered with the Health Ministry and span all major therapeutic categories. These include treatments for cancer, chronic illnesses, and acute conditions.
Among the newly reinstated drugs are a broad range of essential medications, notably antibiotics—marking a critical step toward improving access to treatment for thousands of Lebanese patients.
Comments